Ravi Salgia to Vascular Endothelial Growth Factor Receptor-2
This is a "connection" page, showing publications Ravi Salgia has written about Vascular Endothelial Growth Factor Receptor-2.
Connection Strength
0.119
-
Novel functional germline variants in the VEGF receptor 2 gene and their effect on gene expression and microvessel density in lung cancer. Clin Cancer Res. 2011 Aug 15; 17(16):5257-67.
Score: 0.099
-
Efficacy and safety of bevacizumab plus erlotinib for patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer: a trial of the Chicago, PMH, and California Phase II Consortia. Gynecol Oncol. 2008 Jul; 110(1):49-55.
Score: 0.020